Veriheal
JULY 25, 2023
Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. The positivity rates in 2021 and 2022 were more than 30%, the highest since the all-time low in 2010-2012. The positivity for cannabis in the U.S. in 2021 and 4.3% in 2021 and 1.5%
NORML
JANUARY 28, 2019
The New York State Association of Police said traffic safety is a major concern, citing an increase in vehicle-related fatalities by 62 percent in Colorado the first year cannabis was legalized in the state. 2 years before medical legalization, the largest number of vehicle-related fatalities in the last 17 years. Sales began January 1.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 10, 2021
The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.
Cannabis Law Report
SEPTEMBER 7, 2021
Despite these considerations, HHC vape carts hit the market without an accredited Certificate of Analysis (COA) or toxicity data. Old data suggests that beta-HHC is 1000% more potent than D9-THC. Variations of HHC are even 1000 percent stronger than THC. Plus, production often uses heavy metals. Where does HHC come from? Huffman, J.
Cannabis Law Report
AUGUST 16, 2021
It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child. 600 USD raised of $400 goal.
TheAnswerPage
FEBRUARY 25, 2022
A 2017 federally commissioned report from the National Academies of Sciences, Engineering and Medicine (NASEM) recognized several conditions that have substantial and/or conclusive evidence-based data to support Cannabis’ efficacy. 2010) History of Taxonomy – Lecture from Dept. More on potency will be discussed in future blogs.
Greencamp
APRIL 23, 2019
In 2005, a group of researchers was looking into the effectiveness and long-term safety of tetrahydrocannabinol for MS. In a 2010 study, MS patients were given Sativex (whole-plant formulation with 1:1 THC to CBD ratio), and placebo for 10 weeks. Cannabis for Lupus: Here’s How Cannabinoids Relieve Inflammation.
Expert insights. Personalized for you.
90 
Let's personalize your content